Drug class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
10 drugs the FDA files under Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, and that we can price. Drugs in one class are not interchangeable — they share a mechanism, not a dose or a set of side effects — but the price gap between them is often large, and it is a reasonable thing to raise with a prescriber.
- abacavir 600 MG / dolutegravir 50 MG / lamivudine 300 MG Oral Tablet [Triumeq]Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
- abacavir 600 MG / lamivudine 300 MG Oral TabletHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
- dolutegravir 50 MG / lamivudine 300 MG Oral Tablet [Dovato]Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
- entecavir 0.5 MG Oral TabletHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
- entecavir 1 MG Oral TabletHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
- lamivudine 10 MG/ML Oral SolutionHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
- lamivudine 100 MG Oral TabletHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
- lamivudine 150 MG / zidovudine 300 MG Oral TabletHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
- lamivudine 150 MG Oral TabletHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
- lamivudine 300 MG Oral TabletHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor